Pfizer (PFE) stock has risen 7.3% in the past three months compared with an increase of 2.9% for the industry. The stock has also outperformed the sector as well as the S&P 500, as seen in the chart below.PFE Stock Outperforms Industry, Sector & S&P 500Image Source: Zacks Investment ResearchAnyone can think that rising 7.3% over three months is not a big deal. However, when it comes to Pfizer, it is an important achievement. During the pandemic, Pfizer gave the world the first and most widely used vaccine, ...